Andrew Hertler works in the field of Oncology. He researched medicine at University of Michigan Medical School. Andrew Hertler is a published doctor as well. He has 16 publications published. The latest was: High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer. Dr. Andrew A. Hertler accepts Medicare payments and is listed with Medicare.gov.
NPI NUMBER | 1144296609 | |
NPPES Provider LastName | HERTLER | |
NPPES Provider FirstName | ANDREW | |
NPPES Provider ZIPCode | 043308058 | |
NPPES Provider State | ME | |
Specialty Description | Medical Oncology | |
Total Claim Count | 327.0 | |
Distinct Opioid Count | 1.0 | |
Opioid Claim Count | 30.0 | |
Percent Opioid Claims | 9.17 |
National Provider Identifier [NPI] | 1144296609 |
Last Name Of The Provider | HERTLER |
First Name Of The Provider | ANDREW |
View All |
![]() |
Dr. G R. Polkinghorn, MD |
![]() |
Dr. Abderrahim Khomani, MD
![]() |
![]() |
Dr. Karen A. Backman, MD
![]() |
![]() |
Dr. Elena M. Nawfel, MD
![]() |
![]() |
Dr. Donald G. Magioncalda, MD
![]() |